2021 연구자 정보 (17 / 1141)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
---|---|---|---|---|---|---|---|---|---|---|
Venkatanarayan, Avinashnarayan (Venkatanarayan, A) |
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Venkatramanan, K. (Venkatramanan, K) |
SCSVMV Deemed Univ, Dept Phys, Kanchipuram 631561, Tamil Nadu, India |
N-4628-2016 kannan, venkatramanan |
|
[JCR상위 0.7%] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics | SCIE | 0.7 |
CHEMISTRY, APPLIED CHEMISTRY, PHYSICAL ENERGY & FUELS ENGINEERING, CHEMICAL |
SaiAnand.Gopalan@newcastle.edu.au Quinn.Qiao@sdstate.edu |
||
Western, Luke M. (Western, LM) |
교신저자 | Univ Bristol, Sch Chem, Bristol, Avon, England |
|
0000-0002-0043-711X Western, Luke |
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
Luke.western@bristol.ac.uk rprinn@mit.edu matt.rigby@bristol.ac.uk |
|
Wilson, Gregory J. (Wilson, GJ) |
Newcastle Energy Ctr, CSIRO Energy, 10 Murray Dwyer Cct, Mayfield West, NSW 2304, Australia |
G-3005-2013 Wilson, Gregory |
0000-0003-2575-5488 Wilson, Gregory |
[JCR상위 0.7%] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics | SCIE | 0.7 |
CHEMISTRY, APPLIED CHEMISTRY, PHYSICAL ENERGY & FUELS ENGINEERING, CHEMICAL |
SaiAnand.Gopalan@newcastle.edu.au Quinn.Qiao@sdstate.edu |
||
Yan, Yibing (Yan, YB) |
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Ye, Xin (Ye, X) |
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Yen, Ivana (Yen, I) |
제1저자 | Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
|
Yi, Kijong (Yi, K) |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
Yin, Jianping (Yin, JP) |
Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Youk, Jeonghwan (Youk, J) |
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea |
|
|
[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
ohjiwon@knu.ac.kr ysju@kaist.ac.kr |
||
Zhang, Liangxuan (Zhang, LX) |
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA |
|
|
[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma | SCIE | 0.7 | MULTIDISCIPLINARY SCIENCES |
twkimmd@amc.seoul.kr shivam@gene.com |
||
Acharya, Suman (Acharya, S) |
Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea Yeungnam Univ, Coll Pharm, Gyongsan, South Korea |
AAP-4838-2020 Acharya, Suman |
|
[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway [JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis |
SCIE | 0.8 |
BIOCHEMISTRY & MOLECULAR BIOLOGY ONCOLOGY IMMUNOLOGY |
hjko@kangwon.ac.kr jchang@yu.ac.kr |
||
Ahn, Jae-Hee (Ahn, JH) |
Kangwon Natl Univ, Dept Pharm, Kangwondaehak Gil 1, Chunchon 24341, South Korea |
|
|
[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway | SCIE | 0.8 |
BIOCHEMISTRY & MOLECULAR BIOLOGY ONCOLOGY |
hjko@kangwon.ac.kr jchang@yu.ac.kr |
||
Chang, Jae-Hoon (Chang, JH) |
교신저자 |
Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea Yeungnam Univ, Coll Pharm, Gyongsan, South Korea |
|
|
[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway [JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis |
SCIE | 0.8 |
BIOCHEMISTRY & MOLECULAR BIOLOGY ONCOLOGY IMMUNOLOGY |
hjko@kangwon.ac.kr jchang@yu.ac.kr |
|
Gu, Ye (Gu, Y) |
Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea Yeungnam Univ, Coll Pharm, Gyongsan, South Korea |
|
|
[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway [JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis |
SCIE | 0.8 |
BIOCHEMISTRY & MOLECULAR BIOLOGY ONCOLOGY IMMUNOLOGY |
hjko@kangwon.ac.kr jchang@yu.ac.kr |
페이지 이동: